Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.

Overview
Identity
Additional Document Info
View All

authors

Wallach, Joshua D
Egilman, Alexander C
Dhruva, Sanket S
McCarthy, Margaret E
Miller, Jennifer E
Woloshin, Steven
Schwartz, Lisa M
Joseph S. Ross, MD, MHS

publication date

January 1, 2018

published in

BMJ (Clinical research ed.) Journal

has subject area